STOCK TITAN

Camden Natl Corp SEC Filings

CAC NASDAQ

Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Camden National Corporation SEC filings document formal disclosures for a publicly traded bank holding company and its community banking operations. Material-event reports furnish quarterly and annual earnings releases, dividend declarations, share repurchase authorization, and investor presentation materials.

The company’s proxy filings cover governance and executive-compensation matters, including equity awards and pension-related compensation measures. Together, the filings record Camden National’s reported operating results, capital-return actions, common-stock matters, board oversight, and public-company reporting obligations.

Rhea-AI Summary

Camden National Corporation (CAC) – Form 4 insider filing

Director Raina Maxwell reported the receipt of 307 shares of CAC common stock on 20 June 2025. The shares were issued at $38.57 each under the company’s 2022 Equity and Incentive Plan in lieu of cash director fees.

Following the transaction, Maxwell’s aggregate direct holding increased to 1,759.601 shares. The filing was signed by Christopher G. Hutchinson under power of attorney and submitted on 23 June 2025.

No derivative securities were reported, and there were no dispositions. The transaction was coded “A” (acquisition) and is classified as a routine equity award to a non-employee director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Camden National Corporation (CAC) – Form 4 insider transaction

Director Lawrence J. Sterrs disclosed the purchase of 204 common shares on 20-Jun-2025 at $38.57 per share. The acquisition was made under the company’s 2022 Equity & Incentive Plan as payment in lieu of cash director fees. After the transaction, Sterrs’ direct beneficial ownership rose to 14,351.598 shares.

No derivative securities were involved, no sales were reported, and the filing does not reference a Rule 10b5-1 trading plan. The dollar value of the purchase is approximately $7.9 thousand, representing a negligible portion of both daily trading volume and total shares outstanding; therefore, the filing is best interpreted as routine insider participation rather than a market-moving event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

On 06/20/2025, Camden National Corporation (CAC) director Craig N. Denekas acquired 454 shares of common stock at $38.57 per share, a transaction valued at roughly $17.5 thousand. The shares were issued under the company’s 2022 Equity and Incentive Plan in lieu of cash director fees, as indicated in the Form 4 filed on 06/23/2025.

After this routine equity-based compensation grant, Denekas’ direct holdings increased to 15,080 shares. The filing is coded “A” (acquisition) and does not reference a Rule 10b5-1 trading plan. No derivative securities were involved.

While stock compensation aligns director interests with shareholders, the small size and compensatory nature of this award mean the event is unlikely to affect Camden National’s valuation, liquidity, or governance profile in a material way.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Camden National Corporation (ticker: CAC) filed a Form 4 indicating that director Marie J. McCarthy acquired 388 shares of common stock on 06/20/2025. The shares were issued at an implicit value of $38.57 each under the company’s 2022 Equity and Incentive Plan as compensation in lieu of cash director fees. Following this routine grant, McCarthy’s direct beneficial ownership rises to 15,037.874 shares.

No shares were sold and no derivative securities were involved. The filing, signed by attorney-in-fact Christopher G. Hutchinson on 06/23/2025, contains no additional financial metrics, earnings data, or strategic announcements, making it a standard insider ownership update rather than a materially significant event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Camden Natl (CAC) SEC filings are available on StockTitan?

StockTitan tracks 130 SEC filings for Camden Natl (CAC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Camden Natl (CAC)?

The most recent SEC filing for Camden Natl (CAC) was filed on June 23, 2025.